title: [Optimization of complex treatment in ocular toxoplasmosis and concurrent infections].
abstract: 137 patients (177 eyes) with verified toxoplasmic uveitis, retinitis, chorioretenitis were observed. Among them 65 patients had concurrent infections: tuberculosis, herpes simplex and chlamydia. Routine ophthalmologic, clinical and laboratory examination was performed. The results of intensive treatment in acute and chronic phases are presented, the staged drug pathogenic treatment including methods of specific therapy, based on differential approach to anti-inflammatory agents use, was provided. Early diagnosis and appropriate management including combined treatment of concurrent infections improves treatment efficacy and allows to achieve excellent results.
authors.forename: O K
authors.initials: OK
authors.lastname: Vorob'eva
authors.forename: I Iu
authors.initials: IIu
authors.lastname: Razumova
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D000998:Antiviral Agents / Q000008:administration & dosage; D002689:Chlamydia / Q000187:drug effects / Q000302:isolation & purification; D003941:Diagnostic Techniques, Ophthalmological; D004359:Drug Therapy, Combination / Q000379:methods; D042241:Early Diagnosis; D015817:Eye Infections / Q000175:diagnosis / Q000188:drug therapy* / Q000382:microbiology / Q000821:virology; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests / Q000379:methods; D009161:Mycobacterium / Q000187:drug effects / Q000302:isolation & purification; D055502:Secondary Prevention; D018139:Simplexvirus / Q000187:drug effects / Q000302:isolation & purification; D014126:Toxoplasmosis, Ocular / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D016896:Treatment Outcome
chemical_list: D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D005938:Glucocorticoids